ArticleJACC. Advances2025

Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF.

Andrew J Sauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.